Home Financial Markets Is that the reason why Cellectar Biosciences, Inc. (CLRB), stock muddled in...

Is that the reason why Cellectar Biosciences, Inc. (CLRB), stock muddled in the post market hours Tuesday?

Cellectar Biosciences, Inc. (NASDAQ:CLRB), shares were dipping -22.38% to $2.15 in the ‎after-hours session on Tuesday after the company, focused on the discovery, development ‎and commercialization of new cancer therapies, Cellectar Biosciencesannounced that it ‎plans to offer and sell shares of its common stock and its common stock equivalents in a ‎public offering. There is no guarantee as to whether the offering will be completed, or as to ‎the size or terms of the offering, since it is subject to market conditions.‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

‎Upon completion of the public offering, the Company expects to sell shares of common ‎stock and convertible preferred stock at the public offering price to certain investors in a ‎private placement.‎

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Oppenheimer & Co. Inc. is acting solely as an underwriter in the public offering.‎‎

Get the hottest stocks to trade every day before the ‎market opens 100% ‎free. Click here now. 

‎Under the shelf ‎registration statement previously filed with, and declared effective by, the Securities and ‎Exchange Commission (SEC) on August 20, 2020, Cellectar will issue shares of common stock ‎and common stock equivalents in the public offering. Only the prospectus and it’s ‎supplement will be distributed in connection with this offering. With the Securities and ‎Exchange Commission (SEC), the Company will file an initial prospectus supplement and an ‎accompanying prospectus relating to the public offering. Additional copies of the ‎preliminary prospectus supplement and accompanying prospectus may be obtained by ‎contacting Oppenheimer & Co. Inc. at 85 Broad Street, 26th Floor, New York, NY, 10004, or ‎by emailing EquityProspectus@opco.com.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Pyxis Tankers Inc. (PXS) stock fell during pre-market trading. Why so?

Pyxis Tankers Inc. (NASDAQ: PXS) stock declined by 0.06% at the last close while the PXS stock price plunged by 6.15% in the pre-market...

Why STAAR Surgical Company (STAA) stock went up on Tuesday?

STAAR Surgical Company (STAA) shares rose 5.84% in after-hours on Tuesday, June 22, 2021, and closed the day at $151.25 per share. earlier in...

Related News

Orphazyme Inc. (ORPH) stock plunged during pre-market trading. Let’s see why?

Orphazyme Inc. (NASDAQ: ORPH) stock declined by 10.18% at last close whereas the ORPH stock price fell during the pre-market trading session by 58.18%....

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

General Employment Enterprises Inc. (JOB) stock soars during pre-market trading. Here’s to know why?

General Employment Enterprises Inc. (NASDAQ: JOB) stock gained by 1.96% at last close while the JOB stock price rises by 3.88% in the pre-market...

U.S Concrete Inc. (USCR) stock soars during pre-market trading session. What’s driving it high?

U.S Concrete Inc. (NASDAQ: USCR) stock declined by 0.66% at last close while the USCR stock price gained by 27.88% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.